These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25089078)

  • 1. Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment.
    Urban B; Bakunowicz-Łazarczyk A; Michalczuk M
    Mediators Inflamm; 2014; 2014():971417. PubMed ID: 25089078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune recovery uveitis: a focus review.
    Rodrigues Alves N; Barão C; Mota C; Costa L; Proença RP
    Graefes Arch Clin Exp Ophthalmol; 2024 Aug; 262(8):2703-2712. PubMed ID: 38381160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-associated retinopathy in the HAART era.
    Goldberg DE; Smithen LM; Angelilli A; Freeman WR
    Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy-a 5-year study from Singapore.
    Yeo TH; Yeo TK; Wong EP; Agrawal R; Teoh SC
    J Ophthalmic Inflamm Infect; 2016 Dec; 6(1):41. PubMed ID: 27822743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective study of ocular complications in patients with human immunodeficiency virus infection before and after HAART].
    Hamamotoo A; Tatebayashi M; Uehira A; Kuroda S; Morimoto Y; Nakagawa T; Usui S; Watanabe M; Kazuo K; Otori Y
    Nippon Ganka Gakkai Zasshi; 2012 Aug; 116(8):721-9. PubMed ID: 22973736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune recovery uveitis associated with highly active antiretroviral therapy in a patient with CMV retinitis and AIDS despite a low CD4+ T cell count: case report and a review of the literature.
    Alp MN; Baykam N; Kural G
    Int Ophthalmol; 2010 Apr; 30(2):183-9. PubMed ID: 19198761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
    Schrier RD; Song MK; Smith IL; Karavellas MP; Bartsch DU; Torriani FJ; Garcia CR; Freeman WR
    Retina; 2006 Feb; 26(2):165-9. PubMed ID: 16467672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA; Kendall MA; Owens S; Holland G; Nokta M; Spector SA; Schrier R; Fiscus S; Davis M; Jacobson MA; Currier JS; Squires K; Alston-Smith B; Andersen J; Freeman WR; Higgins M; Torriani FJ;
    HIV Clin Trials; 2005; 6(3):136-46. PubMed ID: 16192248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses.
    Hartigan-O'Connor DJ; Jacobson MA; Tan QX; Sinclair E;
    Clin Infect Dis; 2011 Feb; 52(3):409-17. PubMed ID: 21189271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.
    Jabs DA; Ahuja A; Van Natta M; Lyon A; Srivastava S; Gangaputra S;
    Ophthalmology; 2010 Nov; 117(11):2152-61.e1-2. PubMed ID: 20673591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis.
    Wright ME; Suzman DL; Csaky KG; Masur H; Polis MA; Robinson MR
    Clin Infect Dis; 2003 Apr; 36(8):1063-6. PubMed ID: 12684920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
    Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
    Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
    Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy.
    Sudharshan S; Menia NK; Selvamuthu P; Tyagi M; Kumarasamy N; Biswas J
    Indian J Ophthalmol; 2020 Sep; 68(9):1887-1893. PubMed ID: 32823409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.